Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations

Aims/hypothesisThe weak relationship between insulin resistance and total serum triacylglycerols (TGs) could be in part due to heterogeneity of TG molecules and their distribution within different lipoproteins. We determined concentrations of individual TGs and the fatty acid composition of serum and major lipoprotein particles and analysed how changes in different TGs and fatty acid composition are related to features of insulin resistance and abdominal obesity.MethodsWe performed lipidomic analyses of all major lipoprotein fractions using two analytical platforms in 16 individuals, who exhibited a broad range of insulin sensitivity.ResultsWe identified 45 different TGs in serum. Serum TGs containing saturated and monounsaturated fatty acids were positively, while TGs containing essential linoleic acid (18:2 n−6) were negatively correlated with HOMA-IR. Specific serum TGs that correlated positively with HOMA-IR were also significantly positively related to HOMA-IR when measured in very-low-density lipoproteins (VLDLs), intermediate-density lipoproteins (IDLs) and LDL, but not in HDL subfraction 2 (HDL2) or 3 (HDL3). Analyses of proportions of esterified fatty acids within lipoproteins revealed that palmitic acid (16:0) was positively related to HOMA-IR when measured in VLDL, IDL and LDL, but not in HDL2 or HDL3. Monounsaturated palmitoleic (16:1 n−7) and oleic (18:1 n−9) acids were positively related to HOMA-IR when measured in HDL2 and HDL3, but not in VLDL, IDL or LDL. Linoleic acid was negatively related to HOMA-IR in all lipoproteins.Conclusions/interpretationSerum concentrations of specific TGs, such as TG(16:0/16:0/18:1) or TG(16:0/18:1/18:0), may be more precise markers of insulin resistance than total serum TG concentrations.

[1]  R. Wolfe,et al.  Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men. , 1998, Journal of lipid research.

[2]  Matej Oresic,et al.  Lipidomics: a new window to biomedical frontiers. , 2008, Trends in biotechnology.

[3]  A. Folsom,et al.  Plasma fatty acid composition and incidence of coronary heart disease in middle aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2003, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[4]  G. Lewis,et al.  Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. , 2003, Clinical biochemistry.

[5]  M. Katan,et al.  Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. , 1989, The American journal of clinical nutrition.

[6]  R. Zoeller,et al.  Increasing plasmalogen levels protects human endothelial cells during hypoxia. , 2002, American journal of physiology. Heart and circulatory physiology.

[7]  E. Parks,et al.  Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. , 2005, The American journal of clinical nutrition.

[8]  D. Vance,et al.  Sphingolipid Biosynthesis de Novo by Rat Hepatocytes in Culture. , 1995, The Journal of Biological Chemistry.

[9]  J. Rood,et al.  Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. , 2001, Metabolism: clinical and experimental.

[10]  A. Hamsten,et al.  Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance , 2006, European Journal of Clinical Nutrition.

[11]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[12]  M. Taskinen,et al.  Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM , 1997, Diabetologia.

[13]  B. S. Mohammed,et al.  Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. , 2008, Gastroenterology.

[14]  J. Zeuthen,et al.  Two-site time-resolved immunofluorometric assay of human insulin. , 1986, Clinical chemistry.

[15]  Matej Oresic,et al.  MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data , 2006, Bioinform..

[16]  M. Ohrvall,et al.  The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up. , 1996, Atherosclerosis.

[17]  T. Nikkari,et al.  Fatty acid composition of serum lipid fractions in relation to gender and quality of dietary fat. , 1995, Annals of medicine.

[18]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[19]  K. Pietiläinen,et al.  Liver fat in the metabolic syndrome. , 2007, The Journal of clinical endocrinology and metabolism.

[20]  M. Taskinen,et al.  Metabolic basis of hypotriglyceridemic effects of insulin in normal men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[21]  E. Feskens,et al.  Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study , 2006, Diabetologia.

[22]  J. Huttunen,et al.  Fatty-acid composition of serum lipids predicts myocardial infarction. , 1982, British medical journal.

[23]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[24]  L. Berglund,et al.  The Risk to Develop NIDDM Is Related to the Fatty Acid Composition of the Serum Cholesterol Esters , 1994, Diabetes.

[25]  Yii-Der I. Chen,et al.  Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM , 1988, Diabetes.

[26]  B. Vessby,et al.  Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men , 2005, Diabetologia.

[27]  I. Laakso,et al.  Analysis of fatty acids by gas chromatography, and its relevance to research on health and nutrition , 2002 .

[28]  D. English,et al.  Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. , 2007, The American journal of clinical nutrition.

[29]  B. M. Rasmussen,et al.  Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study , 2001, Diabetologia.

[30]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[31]  J H Eckfeldt,et al.  Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1995, The American journal of clinical nutrition.

[32]  J. Pankow,et al.  Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2003, The American journal of clinical nutrition.

[33]  S. Summers,et al.  Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.

[34]  A. Häkkinen,et al.  Overproduction of large VLDL particles is driven by increased liver fat content in man , 2006, Diabetologia.

[35]  J. Després,et al.  Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome. , 2004, Metabolism: clinical and experimental.

[36]  J. E.,et al.  Serum phospholipid fatty acid composition and insulin action in type 2 diabetic patients , 2001 .

[37]  A. Hamsten,et al.  Measures of Oxidized Low-Density Lipoprotein and Oxidative Stress Are Not Related and Not Elevated in Otherwise Healthy Men With the Metabolic Syndrome , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[38]  M. Kashyap,et al.  A rapid and simple method for measurement of total protein in very low density lipoproteins by the Lowry assay. , 1980, Journal of lipid research.

[39]  M. Taskinen.  Type 2 diabetes as a lipid disorder. , 2005, Current molecular medicine.

[40]  H. Lithell,et al.  Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men , 1994, Diabetologia.

[41]  M. Taskinen,et al.  Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent Diabetes , 1988, Arteriosclerosis.

[42]  A. Häkkinen,et al.  Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. , 2002, The Journal of clinical endocrinology and metabolism.

[43]  A. Kotronen,et al.  Fatty Liver: A Novel Component of the Metabolic Syndrome , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[44]  J. Sundström,et al.  Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. , 2008, The American journal of clinical nutrition.

[45]  R. Mensink,et al.  Fatty acids in serum cholesteryl esters as quantitative biomarkers of dietary intake in humans. , 1997, American journal of epidemiology.

[46]  D. Vance,et al.  Biochemistry of Lipids, Lipoproteins and Membranes , 2002 .

[47]  M. Walker,et al.  Insulin resistance, insulin response, and obesity as indicators of metabolic risk. , 2007, The Journal of clinical endocrinology and metabolism.